Ara
Toplam kayıt 5, listelenen: 1-5
Geographical Variation In Therapy For Bloodstream Infections Due To Multidrug-Resistant Enterobacteriaceae: A Post-Hoc Analysis Of The Increment Study
(Elsevier Science Bv, 2017)
We describe regional differences in therapy for bloodstream infection (BSI) caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Patients (n ...
High Prevalence Of Esbl-Producing Escherichia Coli And Klebsiella Pneumoniae In Community-Onset Bloodstream Infections In China
(Oxford Univ Press, 2017)
Objectives: Community-onset bloodstream infections (COBSIs) caused by ESBL-producing Escherichia coli (ESBLEC) and ESBL-producing Klebsiella pneumoniae (ESBL-KP) are increasing globally. This study aimed to investigate the ...
Efficacy Of Beta-Lactam/Beta-Lactamase Inhibitor Combinations For The Treatment Of Bloodstream Infection Due To Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae In Hematological Patients With Neutropenia
(Amer Soc Microbiology, 2017)
beta-Lactam/beta-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum beta-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy ...
Development And Validation Of The Increment-Esbl Predictive Score For Mortality In Patients With Bloodstream Infections Due To Extendedspectrum- Beta-Lactamase-Producing Enterobacteriaceae
(Oxford Univ Press, 2017)
Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a ...
Epidemiology And Susceptibility Of Pathogens From Smart 2011-12 Turkey: Evaluation Of Hospital-Acquired Versus Community-Acquired Urinary Tract Infections And Icu- Versus Non-Icu-Associated Intra-Abdominal Infections
(Oxford Univ Press, 2017)
Objectives: To describe the epidemiology and susceptibility of pathogens (including ESBL producers) from hospital-acquired (HA) versus community-acquired (CA) urinary tract infections (UTIs) and ICU-versus non-ICU-associated ...